Embodiments described herein relate to evaluating risk of transplant-associated thrombotic microangiopathy. Disclosed herein are methods for determining the risk of developing transplant-associated thrombotic microangiopathy, as well as the likely severity of the outcome. Some embodiments include selecting and administering a treatment for transplant-associated thrombotic microangiopathy in subjects identified as having elevated risk.